So, in an article published yesterday, Morgans is said to have downgraded PNV to Hold from Add but raised its target price to $1.95 from $1.88.
Yet in the financial section of a Newscorp publication the previous day, Morgans put a Sell on PNV, saying that “the wound care company has gained rapid market traction but with the stock having rallied over 50 per cent since November, profit can be taken.”
PNV Media Thread, page-2968
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.35 |
Change
-0.040(1.67%) |
Mkt cap ! $1.623B | |||
| Open | High | Low | Value | Volume |
| $2.41 | $2.41 | $2.34 | $1.491M | 631.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3816 | $2.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.36 | 8900 | 2 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |